Revenue Clarity Consulting for B2B SaaS Founders
The ICP That Closed Your First $1M is Rarely Your Buyer at $3M.
For B2B SaaS founders across fintech, logistics tech, robotics, healthtech, and more, at $1M to $10M ARR whose growth has stalled.
Marketing still sells to last year's buyer. Sales moved on without saying so, and deals close on promises the product can't keep. Noir Dove diagnoses why, then builds the strategy your team runs.
Past $1M ARR, the Founder is Still in Every Deal Above $20K
The gap that is costing you revenue is almost never the one you walked in thinking it was.
Marketing generates leads sales cannot close. Sales wins deals by promising roadmap features that are not built. Churn follows at month six, once the pipeline number stops hiding the problem.
MARKETING
Generates leads sales cannot close
MQLs miss the decision-maker entirely. Marketing optimizes for the ICP it was given in year one. Sales is already pitching a different buyer.
SALES
Closes on promises the product has not shipped
Reps win deals by committing to roadmap features. Customers churn at month six when the product does not match the pitch.
PRODUCT
Builds for the customer who complains, not the one who expands
Enterprise customers with the loudest Slack threads set the roadmap. The buyers who would pay more and refer others never get a seat.
FOUNDER
Still in every deal above $20K
The team cannot close without the founder in the room. Every quarter of this costs a month of product time or the next key hire.
We Have Fixed This Breakdown Across a Range of B2B Categories.
Different products, same underlying failure: the commercial motion was never formally built past founder-led sales. Each category stalls for a different reason on the surface. The root cause repeats.
FINTECH
Compliance officers see risk before they see product.
Founders pitch feature velocity. Compliance and risk teams are evaluating audit trails, uptime guarantees, and regulatory exposure. The deal stalls in a review sales never prepared for.
LOGISTICS TECH
The buyer who signs is rarely the buyer who uses it daily.
Ops managers love the product. Procurement and finance sign the contract, and they are optimizing for cost per shipment, not time saved per dispatcher.
ROBOTICS
Hardware sales cycles run on manufacturing timelines, not SaaS ones.
Founders coming from software pitch on a quarterly cadence. Buyers plan capital expenditure a year out. The narrative and the buying calendar run on different clocks.
HEALTHTECH & DIGITAL HEALTH
Clinical and administrative buyers are different. Most pitches treat them as one.
A founder who built for the clinical buyer pitches to the procurement director. The procurement director forwards it to legal. Nothing moves.
AI-NATIVE & AI-ENABLED FIRMS
Buyers are skeptical of capability claims after being burned by demos.
Narratives built around what the model can do lose to narratives built around what the buyer’s team will be able to do differently.
CYBERSECURITY SAAS & MSSPS
CISOs get hundreds of pitches a year. Most vendors sound identical.
Procurement involves legal, IT, and the board. Each layer needs a different conversation.
Your Buyer Changed. Your Narrative Did Not.
The product evolves every two quarters. The buyer definition rarely gets revisited. Positioning built for the first ICP keeps running long after the company has moved upmarket, and nobody owns the decision to update it.
01
ICP drift after launch
The best buyers in year three look nothing like the ones from year one. The drift goes unnoticed until churn arrives at month twelve.
02
Multi-stakeholder purchase decisions
Economic buyer, technical evaluator, and end user rarely agree on what matters. Each layer needs a different conversation.
03
Roadmap promises sales cannot keep
Reps close on features that do not exist yet. The renewal conversation was already lost at the close.
04
Long sales cycles with no signal
Deals take months with no way to tell a real deal from a polite stall. Forecasting becomes a guess.
B2B SaaS Founders' Core Challenges
Founders Walk In With a Theory. Half the Time, It Is Wrong.
Every engagement surfaces a different root cause. These are the symptoms founders walk in with.
ICP that drifted after launch
The product evolved. The buyer definition did not. Marketing and sales are still targeting year-one customers while the best buyers in year three look completely different.
ICP · BUYING FRICTION
MQLs sales does not recognise
Marketing hits its lead targets every quarter. Sales says the leads are wrong. Both are correct. Marketing is optimising for a buyer sales has moved away from.
CROSS-FUNCTIONAL ALIGNMENT
Deals closed on roadmap promises
Sales closes by promising features not yet built. Churn arrives at month six when the product does not match the pitch.
PIPELINE · REVENUE INTEGRITY
Positioning that misses the buyer
The narrative lands with practitioners. The economic buyer who signs the contract needs a different conversation and is not getting it.
POSITIONING · MESSAGING
Churn product cannot explain
Customers leave at month 6 or 12. Product attributes it to roadmap gaps. In most cases the gap was in the sale, the buyer was sold a future the product was not ready to deliver.
CONVERSION SIGNAL ANALYSIS
Founder still closing every deal
The sales team is hired and ramped. Every deal above $20K still needs the founder in the room, because the pitch was never written down.
COMMERCIAL SCALABILITY
Roadmap disconnected from revenue
The loudest enterprise customer sets the quarterly roadmap. The buyers who would expand ARR and refer peers never have a seat at the planning table.
COMMERCIAL SCALABILITY
New market entry not converting
Strong traction at home. Pilots run in a new geography or vertical, and nothing closes, because the proof and entry narrative never changed.
ICP DEPTH · MARKET NARRATIVE
Diagnosis, Strategy, Alignment.
In That Sequence, Always.
In cybersecurity, executing the wrong strategy costs 6 to 18 months, not one quarter. You leave with a playbook your team can run, not a findings document that sits in a folder.
Diagnosis
Both founders in the room. CRM review, pipeline analysis, team conversations, customer calls.
Strategy
A custom revenue playbook: positioning, ICP definition, pipeline architecture, sales motion.
Alignment
Team sessions across sales, marketing, and product so every function understands its role going forward.
Execution
Guided, trained, or managed through vetted partners. Only after diagnosis, strategy, and alignment are confirmed.
The sequence is not optional. Each step depends on the one before it.
The Cost of Waiting
Every Growth Promiser Sells the Same Fix.
None of Them Ask Why Your Growth Stalled.
More outbound. More content. More campaigns. It is the same prescription every generic GTM consultant writes, & it never touches why a buyer goes quiet or why the deal stalls before signature. You hire a growth promiser, burn a quarter, & the pipeline number does not move.
$150K–$250K
Spent on a sales hire the generic consultant never diagnosed first
6–18 months
Spent running campaigns while deals still stall before signature
15–20 hrs/wk
Founder time spent translating what the agency's content never could
You hired a growth agency & the pipeline stayed flat. A GTM consultant rebuilt the funnel and win rates did not move. Outbound volume went up and deals still stalled before signature. If two or more of these already happened, hiring another generic consultant will not fix it either.
Why Noir Dove Understands B2B SaaS Better
You can hire a LinkedIn ads specialist tomorrow and find a copywriter in 48 hours. A firm that tells you your positioning is wrong before running a single campaign is rare. NoirDove diagnoses before prescribing anything. Measured on structural change and clarity. Tells you when the strategy is the problem. Delivers a playbook your team owns and runs.
Sakshi is direct and structured. Founders who work with her leave knowing exactly what is broken, why it developed, and what has to change first. She makes the diagnosis actionable. Every recommendation comes with a sequence and a reason for the sequence.
Jagsir creates the conditions where founders tell the truth about their business. Real commercial problems surface only when founders feel safe enough to name them. Every recommendation he brings stays grounded in what the team can carry forward without external support.
Deep Domain Expertise
Precise Buyer-Language
Accurate ICP Definitions
Faster Adoption
Higher Credibility
Quicker Success Cycles
Frequently Asked Questions (FAQs)
Are you a marketing agency?
No. We do not run campaigns, manage ad spend, or produce content on retainer. We diagnose why your commercial system is not producing predictable pipeline, then build the strategy your team runs. Execution, when needed, is scoped separately.
Do you work with hardware or robotics companies, not just pure software?
Yes. The commercial system problem is the same whether the product is software, hardware, or a hybrid. We have run diagnostics for robotics and logistics tech founders whose sales cycle runs on a manufacturing or procurement calendar instead of a SaaS one. The fix was still about closing the gap between what the pitch promises and who signs.
We already have a marketing and sales team. How would this work with them?
We do not replace your team or take over execution. The Diagnostic examines how marketing, sales, and product are currently working together. The Strategy phase gives your existing team a playbook to run. The Alignment workshop makes sure every function leaves with the same definition of who you sell to and why.
What if the Diagnostic finds something different from what we expected?
That is the most common outcome. Founders usually walk in believing the problem is positioning, or a broken funnel, or the sales team. The root cause is often somewhere else, most often in how marketing and sales have quietly drifted onto different definitions of the buyer. We show you the evidence, not just the conclusion.
How long does the engagement take?
Diagnosis runs 4 to 6 weeks. Strategy runs 2 to 3 weeks after that. Alignment is a structured workshop once the playbook is built. Most founders have a completed playbook 8 to 10 weeks from kickoff.
Do you help with execution after the Diagnostic and Strategy?
Only where the findings call for it, and only after Diagnosis, Strategy, and Alignment are confirmed. We guide, train, or manage execution through vetted partners. Many founders run execution with their own team using the playbook alone.
Who actually runs the Diagnostic?
Both founders, Sakshi Dhiman and Jagsir Singh, are in every engagement. It is not delegated to a junior analyst. Every application is reviewed by them personally before an engagement starts.
Guessing Costs $150K and Six Months. Finding Out Costs One Conversation.
Talk to both founders directly. We start digging into why your revenue system is stalling, and what it will take to get it compounding again.